Effects of anti-IL-23 and anti-IL-17: The hidden side of spondyloarthritis polymorphism?
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Effects of anti-IL-23 and anti-IL-17: The hidden side of spondyloarthritis polymorphism? |
| Type de publication | Journal Article |
| Year of Publication | 2020 |
| Auteurs | Wendling D, Prati C, Chouk M, Verhoeven F |
| Journal | JOINT BONE SPINE |
| Volume | 87 |
| Pagination | 5-7 |
| Date Published | JAN |
| Type of Article | Editorial Material |
| ISSN | 1297-319X |
| Mots-clés | Axial disease, IL-17, IL-23, Inflammatory bowel disease, Ixekizumab, Risankizumab, Secukinumab, Spondyloarthritis, treatment, Ustekinumab |
| DOI | 10.1016/j.jbspin.2019.06.012 |